Tryptamine Therapeutics (AU:TYP) has released an update.
Tryptamine Therapeutics has disclosed its top 20 shareholders, with COMPUTERSHARE INVESTOR SERVICES INC leading the pack holding a notable 30.61% of the company’s shares. Key individual shareholders include Mr. William James Garner and Jason Alan Carroll, with substantial stakes of 5.27% and 2.63%, respectively. The top 20 collectively hold 55.38% of Tryptamine’s total issued capital, indicating a solid interest from a mix of corporate and private investors.
For further insights into AU:TYP stock, check out TipRanks’ Stock Analysis page.
